Galectin-3 is associated with arterial stiffness among hemodialysis patients

Qi Zhang1,2, Kanhua Yin3, Mingli Zhu2

  • 1Division of Nephrology, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200011, PR China.

Biomarkers in Medicine
|February 28, 2019
PubMed

Insights

Galectin-3 is linked to arterial stiffness in hemodialysis patients. This finding suggests galectin-3 may be a biomarker for cardiovascular risk in this population.

Area of Science:

  • Nephrology
  • Cardiology
  • Biochemistry

Background:

  • Arterial stiffness is a significant cardiovascular risk factor in patients undergoing hemodialysis.
  • Galectin-3, a protein involved in fibrosis and inflammation, has emerged as a potential biomarker for cardiovascular disease.

Purpose of the Study:

  • To investigate the association between serum galectin-3 levels and arterial stiffness in patients receiving hemodialysis.
  • To determine if galectin-3 is an independent predictor of arterial stiffness, even after accounting for traditional cardiovascular risk factors.

Main Methods:

  • A cross-sectional study involving 311 hemodialysis patients.
  • Arterial stiffness was assessed using pulse-wave velocity (PWV > 10 m/s).
  • Serum galectin-3 concentrations were measured and correlated with clinical parameters and cardiovascular risk factors.

Main Results:

  • Galectin-3 levels were associated with dialysis vintage, calcium, phosphorus, and low-density lipoprotein.
  • After adjusting for multiple cardiovascular risk factors, galectin-3 remained independently associated with pulse-wave velocity (partial r = 0.130; p = 0.035).
  • This association persisted even after further adjustment for mean arterial pressure and single-pool Kt/V (partial r = 0.139; p = 0.014).

Conclusions:

  • Serum galectin-3 is independently associated with arterial stiffness in hemodialysis patients.
  • Galectin-3 may serve as a valuable biomarker for assessing cardiovascular risk and arterial stiffness in this vulnerable population.

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
1.6K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
779
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
833
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
489
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH301:11

orthopara-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3

All ortho–para directors, excluding halogens, are activating groups. These groups donate electrons to the ring, making the ring carbons electron-rich. Consequently, the reactivity of the aromatic ring towards electrophilic substitution increases. For instance, the nitration of anisole is about 10,000 times faster than the nitration of benzene. The electron-donating effect of the methoxy group in anisole activates the ortho and para positions on the ring and stabilizes the corresponding...
7.4K
Arteries of Lower Limbs01:20

Arteries of Lower Limbs

The external iliac artery transitions out of the body cavity, entering the femoral region of the lower leg, and is renamed the femoral artery at the point where it traverses the body wall. This artery is responsible for the distribution of blood to the thigh's deep muscles and the skin's ventral and lateral regions, achieved through several minor branches and the lateral deep femoral artery, which also spawns a lateral circumflex artery. The knee area receives blood from the genicular...
4.5K